Using a quick test and a treatment plan to choose the right antibiotics for pneumonia in the ICU
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are on a breathing machine in the ICU and have been in the hospital for at least 2 days.
- You have been diagnosed with ventilator-associated pneumonia within the last 12 hours.
- You are already receiving antibiotics for this pneumonia.
- You are not pregnant, and do not have certain severe immune problems or recent treatments that affect your immune system.
- You do not have a known allergy to beta-lactam antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares starting antibiotics right away versus waiting for more test results in people on a breathing machine who may have pneumonia. The goal is to find out which approach works better without causing harm.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This trial tests a new way to better understand lung infections in very sick ICU patients. It looks at people with septic shock, severe trauma, or major burns to see if an infection is the cause.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial tests whether doctors can safely reduce or stop some antibiotics earlier for patients on breathing machines who develop pneumonia in the ICU. It looks at using lab results to guide treatment, which might lower side effects from unnecessary antibiotics.
Hear when a new Ventilator Associated Pneumonia ( VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.